Updates are available Correction dated 2021-10-12
Click to view Correction: https://doi.org/10.1038/s41467-021-26287-8
-
Authors
Ajiro, Masahiko
Awaya, Tomonari https://orcid.org/0000-0002-9004-3172
Kim, Young Jin
Iida, Kei https://orcid.org/0000-0001-7130-8705
Denawa, Masatsugu https://orcid.org/0000-0001-5808-8197
Tanaka, Nobuo
Kurosawa, Ryo https://orcid.org/0000-0002-6710-9989
Matsushima, Shingo
Shibata, Saiko
Sakamoto, Tetsunori
Studer, Lorenz https://orcid.org/0000-0003-0741-7987
Krainer, Adrian R.
Hagiwara, Masatoshi https://orcid.org/0000-0002-7079-4788
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP18kk0305003h0003, 19ek0109327h0002, 19lm0203054h0002)
MEXT | Japan Society for the Promotion of Science (15H05721)
- License Information
-
More Information
Article History
Received: 15 May 2020
Accepted: 21 June 2021
First Online: 23 July 2021
Change Date: 12 October 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-021-26287-8
Competing interests
: S.M. and S.S. are employees of Kyorin Pharmaceutical Co., Ltd. M.H. is a founder, shareholder, and member of the scientific advisory board of KinoPharma, Inc., and BTB Drug Development Research Center Co., Ltd. The remaining authors declare no competing interests.
